I honestly have no idea and quite frankly, it’s none of my business what they did, or did not get.
When I said Novartis overpaid I was referring to the product “Xiidra”.
The botched transition with the Shire people was referring to the mixed messages Novartis was telling its Eye Care Team and then what they were telling Shire Reps. It was handle poorly at best. Lots of people on both side were hurt unnecessarily in my opinion by deceptive, and misleading statements.
